Healthcare
Rapid Micro Biosystems, Inc.(RPID)
Live Price
Offline$1.71
+1.79% today
1Y Change
-48.49%
Window
Jun 20, 2025 โ Jun 18, 2026
- Market Cap
- $120.00M
- Revenue Growth
- +19.7%
- EPS Growth
- +2.8%
- Dividend Yield
- 0.0%
Coverage: 250 bars ยท Jun 20, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rapid Micro Biosystems, Inc. (RPID) is a Healthcare stock with a market cap of $120.00M and listed on NASDAQ. The stock last traded around $1.71 and down 48.5% across the available one-year price window (Jun 20, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +19.7%, EPS growth of +2.8%, a dividend yield of 0.0%. What stands out right now is revenue +19.7%, EPS +2.8%, free cash flow +29.9% with operating margin -141.1% and ROIC -82.2%. Valuation is more restrained than many high-expectation growth names at price/sales 3.4. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RPID price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+19.7% vs +7.6% peer median
Operating Margin
Below sector median
-141.1% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2026 was reported on May 13, 2026 with an EPS surprise of -24.0% and a revenue surprise of +5.3%.
The operating story is still moving forward
Revenue is running at +19.7% and EPS at +2.8%, with operating margin around -141.1%.
The next real check-in already has a date
The next earnings event is scheduled for Aug 11, 2026, which is the clearest near-term catalyst for confirming whether the current trend is holding up.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -3.4% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 13, 2026 | -24.0% | -6.5% | -19.0% | -24.2% |
2026 Mar 12, 2026 | -21.7% | -17.4% | -27.0% | -38.1% |
2025 Nov 7, 2025 | +0.0% | +4.5% | +35.8% | +28.4% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RPID
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RPID Max Drawdown
-64.53%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RPID and SPY.
Company Overview
Rapid Micro Biosystems, Inc.
NASDAQ Global Select
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
- Leadership
- Robert G. Spignesi Jr.
- IPO Date
- Jul 15, 2021
- Employees
- 163
- Street Address
- 1001 Pawtucket Boulevard West
- Mailing
- Lowell, MA, 01854
- Region
- Lowell, MA, US
- Reporting Currency
- USD
- Investor Line
- 978 349 3200
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 3.4
- Price/Book
- 3.4
Growth
- Revenue
- +19.7%
- EPS
- +2.8%
- Free Cash Flow
- +29.9%
Profitability
- Gross Margin
- 17.4%
- Operating Margin
- -141.1%
- Net Margin
- -140.3%
- ROE
- -95.4%
- ROIC
- -82.2%
Balance Sheet
- Debt/Equity
- 0.72
- Current Ratio
- 3.31
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.